GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmsynthez PJSC (MIC:LIFE) » Definitions » Beta

Pharmsynthez PJSC (MIC:LIFE) Beta : N/A (As of May. 18, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Pharmsynthez PJSC Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-18), Pharmsynthez PJSC's Beta is Not available.


Pharmsynthez PJSC Beta Historical Data

The historical data trend for Pharmsynthez PJSC's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmsynthez PJSC Beta Chart

Pharmsynthez PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.96 0.82 1.01 0.92 1.44

Pharmsynthez PJSC Semi-Annual Data
Dec11 Jun13 Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.92 1.41 1.44 1.44

Competitive Comparison of Pharmsynthez PJSC's Beta

For the Biotechnology subindustry, Pharmsynthez PJSC's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmsynthez PJSC's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmsynthez PJSC's Beta distribution charts can be found below:

* The bar in red indicates where Pharmsynthez PJSC's Beta falls into.



Pharmsynthez PJSC Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Pharmsynthez PJSC  (MIC:LIFE) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Pharmsynthez PJSC Beta Related Terms

Thank you for viewing the detailed overview of Pharmsynthez PJSC's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmsynthez PJSC (MIC:LIFE) Business Description

Traded in Other Exchanges
N/A
Address
150 Engelsa Prospect, St. Petersburg, RUS, 194358
Pharmsynthez PJSC is a pharmaceutical company developing new medications, technologies of drugs for organ-specific delivery and innovative methods of manufacture for pharmaceutical ingredients. The company is engaged in the research and development, production and sales of officinal medicines (original OM) and active pharmaceutical ingredients (API).

Pharmsynthez PJSC (MIC:LIFE) Headlines

From GuruFocus

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment

By Value_Insider Value_Insider 12-15-2022